TORRANCE, CA, - Phenomenex Inc., a Danaher company and global leader in advanced technologies for the separation sciences, today announced the appointment of Dr. Lauryn Bailey as President of Phenomenex. Dr. Bailey joined Phenomenex in 2022 and has played an important role in advancing the company’s commercial and strategic priorities.

“I’m honored to lead Phenomenex and build on the strong foundation created by our talented global teams,” said Dr. Lauryn Bailey, President of Phenomenex. “As scientists work to solve increasingly complex challenges across research, development, manufacturing, and applied markets, they need partners who can help them move faster with confidence. Phenomenex has a proud legacy of advancing separation science, and I believe our greatest opportunities lie ahead. By combining scientific expertise, innovative technologies, and close collaboration, we can help accelerate the journey from insight to impact and enable discoveries that improve human health and our world.”

With deep scientific expertise and more than a decade of commercial leadership experience, Dr. Bailey has partnered with customers across life sciences and applied markets to advance innovation, improve outcomes, and accelerate discovery. In her new role, she will lead Phenomenex's next phase of growth, expanding the company's role as a trusted partner to scientists worldwide. Under her leadership, Phenomenex will continue advancing chromatography and separation science through differentiated technologies, deep application expertise, and a commitment to helping customers solve their toughest analytical challenges.

Dr. Bailey succeeds Dr. Kaveh Kahen who served as Phenomenex’s President since 2024.

About Phenomenex
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in academic, pharmaceutical, biotech, environmental, clinical research, government, and industrial laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve human health and well-being. Phenomenex is an operating company within the Life Sciences group of Danaher Corporation.

About Danaher
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Through our connected ecosystem of industry-leading businesses, we work side by side with customers to solve their most complex scientific and clinical challenges, helping move innovations from discovery to delivery faster for patients who depend on them. Powered by the Danaher Business System, our advanced science and technology and proven ability to innovate help enable faster, more accurate diagnoses and reduce the time, cost, and risk required to discover, develop, and deliver life-changing therapies. Through continuous improvement and operational excellence, our approximately 60,000 associates worldwide are focused on delivering lasting impact and improving quality of life around the world, while building a healthier, more sustainable tomorrow. Explore more at www.danaher.com.​

Media Contact: Jannette Avila, Brand and Public Relations  |  jannettea@phenomenex.com